Article Information
History
- July 7, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Ricky D. Turgeon, BSc(Pharm), ACPR, PharmD, Assistant Professor, Clinical Pharmacy Specialist1,2,*,
- Arden R. Barry, BSc, BSc(Pharm), ACPR, PharmD, Assistant Professor (Partner), Clinical Pharmacy Specialist3,4 and
- Blair MacDonald, BA(Phil), Doctor of Pharmacy Student5
- 1Greg Moore Professorship in Clinical & Community Cardiovascular Pharmacy, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada
- 2St. Paul’s Hospital, Vancouver, BC, Canada
- 3Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada
- 4Chilliwack General Hospital, Lower Mainland Pharmacy Services, Chilliwack, Canada
- ↵*Correspondence to:
Dr. Ricky D. Turgeon, Faculty of Pharmaceutical Sciences, University of British Columbia, 2405 Wesbrook Mall, Vancouver, BC, V6T 1Z3, Canada. Email: ricky.turgeon{at}ubc.ca
Posted July 07, 2022.
Decisional Needs and Patient Treatment Preferences for Heart Failure Medications: Scoping Review Protocol
